(Q34590652)

3 August 2017

title

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy (English)

1 reference

3 August 2017

1 reference

0 references

1 reference

Tony M Korman

6

0 references

Grant W Waterer

9

object named as

Grant W Waterer

1 reference

3 August 2017

14

Graeme R Nimmo

1 reference

3 August 2017

Patrick G P Charles

1

1 reference

3 August 2017

Michael Whitby

2

1 reference

3 August 2017

Andrew J Fuller

3

1 reference

3 August 2017

Robert Stirling

4

1 reference

3 August 2017

Alistair A Wright

5

1 reference

3 August 2017

Peter W Holmes

7

1 reference

3 August 2017

Keryn J Christiansen

8

1 reference

3 August 2017

Robert J P Pierce

10

1 reference

3 August 2017

Barrie C Mayall

11

1 reference

3 August 2017

John G Armstrong

12

1 reference

3 August 2017

Michael G Catton

13

1 reference

3 August 2017

Barbara Johnson

15

1 reference

3 August 2017

Michelle Hooy

16

1 reference

3 August 2017

M L Grayson

17

1 reference

3 August 2017

Australian CAP Study Collaboration

18

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

Clinical Infectious Diseases

3 August 2017

published in

1 reference

3 August 2017

volume

46

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

1513-1521

1 reference

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

3 August 2017

cites work

1 reference

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

Community acquired pneumonia in north eastern Australia--a hospital based study of aboriginal and non-aboriginal patients

21 January 2018

1 reference

Aldosterone and its mechanism of action: more questions than answers

21 January 2018

1 reference

Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction

21 January 2018

1 reference

Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan

21 January 2018

1 reference

Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003.

21 January 2018

1 reference

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

21 January 2018

1 reference

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

Etiology of community-acquired pneumonia in patients requiring hospitalization

21 January 2018

1 reference

Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

21 January 2018

1 reference

Severe community-acquired pneumonia. Assessment of severity criteria

21 January 2018

1 reference

Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?

21 January 2018

1 reference

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia

21 January 2018

1 reference

Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors

21 January 2018

1 reference

Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia

21 January 2018

1 reference

Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia

21 January 2018

1 reference

Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical

21 January 2018

1 reference

Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia

21 January 2018

1 reference

Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy

21 January 2018

1 reference

Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmen

21 January 2018

1 reference

Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia

21 January 2018

1 reference

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

Levofloxacin failure in a patient with pneumococcal pneumonia

21 January 2018

1 reference

Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia

21 January 2018

1 reference

Quinolone resistance among pneumococci: therapeutic and diagnostic implications

21 January 2018

1 reference

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae

21 January 2018

1 reference

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/586749

1 reference

3 August 2017

1 reference